As of November 6, 2026, 5 holders' latest Schedule 13D or 13G filings report owning 5% or more of Bunge Global SA. The largest reported stake is Glencore plc's, at 16.4%. 9 filings are on record since July 7, 2025 (Schedule 13D, July 7, 2025).
Sell to companies like Bunge Global SA? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Capital World Investors · Percent: 10.7% · SCHEDULE 13G/A
- · Holder: Vanguard Capital Management · Percent: 5.47% · SCHEDULE 13G
- · Holder: The Vanguard Group · Percent: 0% · SCHEDULE 13G/A
- · Holder: Capital World Investors · Percent: 8.3% · SCHEDULE 13G/A
- · Holder: State Street Corporation · Percent: 3.5% · SCHEDULE 13G
Bunge Global SA has 9 Schedule 13D or 13G filings on record since 2025-07-07. 5 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Glencore plc | 16.4% | 32,806,103 | SCHEDULE 13D, 2025-07-07 | 2025-07-02 |
| Canada Pension Plan Investment Board | 13.1% | 26,244,732 | SCHEDULE 13D, 2025-07-08 | 2025-07-02 |
| Capital World Investors | 10.7% | 20,695,292 | SCHEDULE 13G/A, 2026-05-14 | 2026-03-31 |
| BlackRock, Inc. | 7.1% | 14,152,788 | SCHEDULE 13G/A, 2025-10-17 | 2025-09-30 |
| Vanguard Capital Management | 5.47% | 10,599,104 | SCHEDULE 13G, 2026-04-28 | 2026-03-31 |
| State Street Corporation | 3.5% | 6,921,849 | SCHEDULE 13G, 2025-11-10 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind Bunge Global SA and the warning signs.
Free to see. No signup.
Keep reading
More on Bunge Global SA and the records around it.
Bunge Global SA elsewhere on the record
- Leadership changes Sep 2026
- Who owns it
Companies that share a holder
- Glencore plc also filed stake reports on 2 other companies: MAC Copper Ltd (Nov 2025), Li-Cycle Holdings Corp. (Aug 2025)
- Canada Pension Plan Investment Board also filed stake reports on 12 other companies: ReNew Energy Global plc (Oct 2026), Americold Realty Trust, Inc. (Aug 2026), Chewy, Inc. (Aug 2026)
- Capital World Investors also filed stake reports on 125 other companies: New Fortress Energy Inc. (Oct 2026), Aura Minerals Inc. (Oct 2026), Skyworks Solutions, Inc. (Oct 2026)
Watch Bunge Global SA
Get an email when Bunge Global SA files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Bunge Global SA?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bunge Global SA: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bunge Global SA covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Glencore plc
The information set forth or incorporated by reference in Items 3, 5 and 6 of this Schedule 13D is incorporated by reference into this Item 4. The Reporting Persons acquired the securities of the Issuer covered by this Schedule 13D for investment purposes. However, the Reporting Persons will continually evaluate the Issuer's business, financial condition, results of operations, capital structure, management, synergies, stock market performance, competitive outlook and other relevant factors. As part of such evaluations, the Reporting Persons will seek the views of, hold discussions with, and respond to inquiries from representatives of the Issuer and other persons regarding the Issuer's affairs. Depending on the results of such evaluations, the Reporting Persons may at any time and from time to time, subject to the restrictions set forth in the Shareholder's Agreement (as defined below), (i) purchase, receive in a distribution or other transfer or otherwise acquire Registered Shares, other securities of the Issuer or instruments convertible into or exercisable for any such securities (collectively, "Issuer Securities"), (ii) sell, transfer, distribute or otherwise dispose of Issuer Securities in the open market, in privately negotiated transactions or otherwise (including entering into derivative transactions to hedge market risk), and (iii) engage in or encourage communications with the Issuer, members of management and the board of directors of the Issuer (the "Issuer …The first part of Item 4 of the SCHEDULE 13D filed 2025-07-07; the filing has the rest
Canada Pension Plan Investment Board
The information set forth or incorporated by reference in Items 3, 5 and 6 of this Schedule 13D is incorporated by reference into this Item 4. The Reporting Persons acquired the securities of the Issuer covered by this Schedule 13D for investment purposes as part of their ordinary business and investing activities. Subject to certain exceptions, limitations and applicable law, pursuant to the Shareholder's Agreement, dated as of the Closing Date, by and between the Issuer and CPPIB Monroe (the "Shareholder's Agreement"), CPPIB Monroe is entitled to (i) nominate two individuals to the Issuer Board so long as the Reporting Persons (and any affiliates) continue to own at least 10% of the total outstanding shares of the Issuer and (ii) nominate one individual to the Issuer Board so long as the Reporting Persons (and any affiliates) continue to own at least 5% but no more than 10% of the total outstanding shares of the Issuer. In addition, the Shareholder's Agreement imposes on CPPIB Monroe (a) certain customary lockup obligations, with certain exceptions, for a period of one year following the Closing Date, (b) a prohibition on transfers to the Issuer's competitors and activist investors, (c) certain non-solicitation and non-compete obligations, with certain exceptions, until the later of (i) three years following the Closing Date and (ii) six months following the date CPPIB Monroe no longer has a director serving on the Issuer Board, (d) a customary "standstill" for CPPIB …The first part of Item 4 of the SCHEDULE 13D filed 2025-07-08; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-07 | Glencore plc | 16.4% | SCHEDULE 13D |
| 2025-07-08 | Canada Pension Plan Investment Board | 13.1% | SCHEDULE 13D |
| 2025-10-17 | BlackRock, Inc. | 7.1% | SCHEDULE 13G/A |
| 2025-10-30 | The Vanguard Group | 8.39% | SCHEDULE 13G/A |
| 2025-11-10 | State Street Corporation | 3.5% | SCHEDULE 13G |
| 2025-11-13 | Capital World Investors | 8.3% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-28 | Vanguard Capital Management | 5.47% | SCHEDULE 13G |
| 2026-05-14 | Capital World Investors | 10.7% | SCHEDULE 13G/A |
Questions about who owns Bunge Global SA
Who owns Bunge Global SA?
On this page, 5 holders' latest ownership filings report 5% or more of Bunge Global SA: Glencore plc (16.4%, Schedule 13D, filed 2025-07-07), Canada Pension Plan Investment Board (13.1%, Schedule 13D, filed 2025-07-08), Capital World Investors (10.7%, Schedule 13G/A, filed 2026-05-14), BlackRock, Inc. (7.1%, Schedule 13G/A, filed 2025-10-17) and Vanguard Capital Management (5.47%, Schedule 13G, filed 2026-04-28).
Who are the largest shareholders of Bunge Global SA?
By the share each holder's latest filing reports, the largest holders of Bunge Global SA on this page are Glencore plc (16.4%), Canada Pension Plan Investment Board (13.1%) and Capital World Investors (10.7%).
When did Glencore plc buy into Bunge Global SA?
The filings give report dates, not purchase dates. The earliest filing from Glencore plc on this page is the Schedule 13D, filed 2025-07-07, reporting 16.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Bunge Global SA
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 5, 2026 | Leadership change: Joseph Podwika departs, Chief Legal Officer | — | Leadership changes | Source |
| September 3, 2026 | Leadership change: Matt Simmons departs, Chief Accounting Officer | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Bunge Global SA. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.